Thermo Fisher Scientific expands animal diagnostics business

Thermo Fisher Scientific completes acquisition of Prionics, a privately held animal health diagnostics company.

Thermo Fisher Scientific Inc. announced March 18 that it has completed the acquisition of Prionics AG, a privately held animal health diagnostics company.

Founded in 1997, Prionics is headquartered in Zurich, Switzerland, and has a major production facility in Lelystad, the Netherlands. Prionics’ product line of more than 50 diagnostic test kits, accessories and biochemicals expands the portfolio of animal health testing products under the Life Technologies brand.

"Prionics adds a unique blend of expertise and diagnostic solutions to new and existing customers," said Kirk Adams, global animal health leader for Thermo Fisher Scientific. "Improved accessibility to animal testing benefits both veterinarians and livestock producers."

According to the announcement, Prionics brings a state-of-the-art infrastructure along with a certified tuberculin manufacturing facility, plus additional enzyme-linked immunosorbent assays (ELISA) under the Life Technologies brand.

Thermo Fisher Scientific has revenues of $17 billion and 50,000 employees in 50 countries. Its four premier brands — Thermo Scientific, Life Technologies, Fisher Scientific and Unity Lab Services — offer a combination of innovative technologies, purchasing convenience and comprehensive support.

Hide comments

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish